Drug-induced lupus as a cause of relapsing inflammatory disease after renal transplantation

Pediatr Transplant. 2002 Aug;6(4):337-9. doi: 10.1034/j.1399-3046.2002.02002.x.

Abstract

We discuss the case of an 18-year-old-boy presenting with relapsing fever, arthralgia, myalgia and renal failure, 7 yr after renal transplantation. A thorough diagnostic work-up for infectious and inflammatory diseases revealed a mastoiditis and atypical mycobacteria, but symptoms persisted after treatment. Persistent antinuclear antibodies in combination with cardiolipin and myeloperoxidase antibodies, despite negative dsDNA antibodies, suggested a drug induced lupus-like syndrome. Six months after withdrawal of dihydralazine, all symptoms had disappeared. Drug-induced lupus should be considered as an important differential diagnosis in transplanted patients with recurrent inflammatory disease in conjunction with lupus-like symptoms and negative dsDNA antibodies. It may prevent a potentially hazardous reduction of immunosuppression in persistent inflammation.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antihypertensive Agents / adverse effects*
  • Diagnosis, Differential
  • Dihydralazine / adverse effects*
  • Humans
  • Kidney Transplantation*
  • Lupus Erythematosus, Systemic / chemically induced*
  • Lupus Erythematosus, Systemic / diagnosis
  • Male
  • Recurrence
  • Syndrome

Substances

  • Antihypertensive Agents
  • Dihydralazine